GE Healthcare Technologies Inc
NASDAQ:GEHC

Watchlist Manager
GE Healthcare Technologies Inc Logo
GE Healthcare Technologies Inc
NASDAQ:GEHC
Watchlist
Price: 79.06 USD -0.28% Market Closed
Market Cap: 36.1B USD
Have any thoughts about
GE Healthcare Technologies Inc?
Write Note

GE Healthcare Technologies Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GE Healthcare Technologies Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
GE Healthcare Technologies Inc
NASDAQ:GEHC
Research & Development
-$1.2B
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Research & Development
-$1.2B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
-8%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$1.5B
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
-6%
Stryker Corp
NYSE:SYK
Research & Development
-$1.4B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.7B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.1B
CAGR 3-Years
-21%
CAGR 5-Years
-16%
CAGR 10-Years
-20%
No Stocks Found

GE Healthcare Technologies Inc
Glance View

Market Cap
36.1B USD
Industry
Health Care

GE Healthcare Technologies Inc. operates as a pivotal player in the vast landscape of medical technology, skillfully weaving a narrative that integrates cutting-edge innovation with practical application. As a segment originally spun out from the iconic General Electric Company, GE Healthcare focuses on enhancing diagnostics and patient care through its advanced imaging and monitoring systems. The company's portfolio spans a wide range of products, including magnetic resonance imaging (MRI) machines, ultrasound devices, and computed tomography (CT) scanners, each designed to provide medical professionals with critical insights needed for accurate diagnosis and effective treatment. By leveraging decades of engineering expertise and a rich history in innovation, GE Healthcare not only improves hospital efficiencies but also supports personalized healthcare solutions that help in the early detection and effective management of diseases. Their revenue model is primarily centered around the sale of these high-technology machines and the accompanying service agreements that ensure their seamless operation. Additionally, the company generates income from its work in life sciences, offering a suite of applications and software that assist in drug discovery and bioprocessing. Combining hardware sales with recurring revenue streams from maintenance services and digital solutions enhances the company’s financial stability. This multifaceted approach positions GE Healthcare as both a stalwart in existing medical technology fields and a pioneer exploring the frontiers of healthcare innovations, driven by a mission to improve patient outcomes worldwide.

GEHC Intrinsic Value
90.06 USD
Undervaluation 12%
Intrinsic Value
Price

See Also

What is GE Healthcare Technologies Inc's Research & Development?
Research & Development
-1.2B USD

Based on the financial report for Dec 31, 2023, GE Healthcare Technologies Inc's Research & Development amounts to -1.2B USD.

What is GE Healthcare Technologies Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-14%

Over the last year, the Research & Development growth was -17%. The average annual Research & Development growth rates for GE Healthcare Technologies Inc have been -14% over the past three years .

Back to Top